Literature DB >> 20962674

Treatment of Gorham-Stout disease with zoledronic acid and interferon-α: a case report and literature review.

Dawn K Kuriyama1, Sean C McElligott, Darryl W Glaser, Karen S Thompson.   

Abstract

Gorham-Stout disease is a rare disease characterized by osteolysis, angiomatosis, and soft-tissue swelling. It is a diagnosis of exclusion and has an unknown etiology. Chylothorax is a common complication of the disease that is associated with a high mortality rate. There is no standard of treatment. We report a case of a 16-year-old female with Gorham-Stout disease and recurrent pleural effusions who was successfully treated with concurrent zoledronic acid and peg-interferon α-2b.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20962674     DOI： 10.1097/MPH.0b013e3181edb464

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN： 1077-4114            Impact factor:   1.289


  15 in total

1.  Zoledronic acid : Treatment option for Gorham-Stout disease.

Authors:  Ozge Gulsum Illeez; Korhan Ozkan; Feyza Unlu Ozkan; Ali Burak Bostan; Fuat Akpinar; Bilge Bilgic; Ilknur Aktas
Journal:  Orthopade       Date:  2018-12       Impact factor: 1.087

2.  Thoracic osteotomy for Gorham-Stout disease of the spine: a case report and literature review.

Authors:  C Maillot; T Cloche; J-C Le Huec
Journal:  Eur Spine J       Date:  2014-10-21       Impact factor: 3.134

Review 3.  Novel molecular pathways in Gorham disease: implications for treatment.

Authors:  Jeroen Hagendoorn; Torunn I Yock; Inne H M Borel Rinkes; Timothy P Padera; David H Ebb
Journal:  Pediatr Blood Cancer       Date:  2013-11-08       Impact factor: 3.167

4.  Vanishing Act: Gorham-Stout Disease Leading to Dynamic Cerebrospinal Fluid Abnormalities.

Authors:  Jason H Peragallo; Bruno P Soares
Journal:  J Neuroophthalmol       Date:  2018-09       Impact factor: 3.042

Review 5.  Rare bone diseases and their dental, oral, and craniofacial manifestations.

Authors:  B L Foster; M S Ramnitz; R I Gafni; A B Burke; A M Boyce; J S Lee; J T Wright; S O Akintoye; M J Somerman; M T Collins
Journal:  J Dent Res       Date:  2014-04-03       Impact factor: 6.116

6.  Gorham-Stout disease: radiological, histological, and clinical features of 12 cases and review of literature.

Authors:  Yi Liu; Ding-Rong Zhong; Pei-Ran Zhou; Fang Lv; Dou-Dou Ma; Wei-Bo Xia; Yan Jiang; Ou Wang; Xiao-Ping Xing; Mei Li
Journal:  Clin Rheumatol       Date:  2014-09-18       Impact factor: 2.980

Review 7.  Cystic angiomatosis, a heterogeneous condition: Four new cases and a literature review.

Authors:  Aurélie Najm; Elise Soltner-Neel; Benoît Le Goff; Pascale Guillot; Yves Maugars; Jean-Marie Berthelot
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

8.  Systemic Cystic Angiomatosis Mimicking Metastatic Cancer: A Case Report and Review of the Literature.

Authors:  Vivek Kumar; Trishala Meghal; Yanyu Helen Sun; Yiwu Huang
Journal:  Case Rep Med       Date:  2017-09-11

9.  Left Functional Pneumonectomy Caused by a Very Rare Giant Intrathoracic Cystic Lesion in a Patient with Gorham-Stout Syndrome: Case Report and Review of the Literature.

Authors:  Nikolaos Tasis; Ioannis Tsouknidas; Argyrios Ioannidis; Konstantinos Nassiopoulos; Dimitrios Filippou
Journal:  Case Rep Pulmonol       Date:  2018-04-12

10.  VEGF-C promotes the development of lymphatics in bone and bone loss.

Authors:  Devon Hominick; Asitha Silva; Noor Khurana; Ying Liu; Paul C Dechow; Jian Q Feng; Bronislaw Pytowski; Joseph M Rutkowski; Kari Alitalo; Michael T Dellinger
Journal:  Elife       Date:  2018-04-05       Impact factor: 8.140
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.